Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (1612)	10/26/2005 4:25:49 PM
From: tuck	Read Replies (1) \| Respond to of 1826

Thanks, so have they mentioned that they are looking for a European partner? >>I too believe this is an overreaction.<< I would guess that analysts, if they view the European market as you do, would also not be factoring in much revenue from there, and as such, today is indeed an overeaction. I finished my MOGN buying spree today. You may have seen recent chatter suggesting MOGN, among others, as munch candidates. It's got to be looking pretty attractive now, just based on Aloxi. I have no idea if Moulder and Co. are looking to sell or empire build. Cheers, Tuck